Attached files
file | filename |
---|---|
EX-99.1 - PROLOR Biotech, Inc. | v186609_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities and Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 26,
2010
PROLOR
BIOTECH, INC.
(Exact
Name of Registrant as Specified in Its Charter)
Nevada
|
000-52691
|
20-0854033
|
||
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
3
Sapir Street
Weizmann
Science Park
Nes-Ziona,
Israel 74140
|
(Address
of Principal Executive Office)
|
Registrant’s
telephone number, including area code (866)
644-7811
(Former Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
ITEM
7.01 Regulation
FD Disclosure.
On May
26, 2010, PROLOR Biotech, Inc., a Nevada corporation (the “Company”), issued a
press release announcing that it has been authorized to list its common stock,
par value $0.00001 per share, on the Tel Aviv Stock Exchange. A copy of the
press release is furnished hereto as Exhibit 99.1 and incorporated by reference
in this Item 7.01.
The
information contained in this Current Report on Form 8-K, including Exhibit
99.1, shall not be deemed “filed” with the Securities and Exchange Commission
nor incorporated by reference in any registration statement filed by the Company
under the Securities Act.
ITEM
9.01. Financial
Statements and Exhibits.
|
(d) Exhibits.
|
Exhibit
Number
|
Description
|
||
99.1
|
Press
Release dated May 26, 2010.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
PROLOR BIOTECH, INC. | |||
Date: May
26, 2010
|
By:
|
/s/ Shai Novik | |
Shai Novik | |||
President | |||
EXHIBIT
INDEX
Exhibit
Number
|
Description
|
||
99.1
|
Press
Release dated May 26, 2010.
|